Hillsdale Investment Management’s Halozyme HALO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.11M	Buy	110,050 +2,600	+2%	+$183K	0.19%	117
2025 Q4	$7.23M	Buy	107,450 +13,450	+14%	+$905K	0.2%	121
2025 Q3	$6.89M	Sell	94,000 -400	-0.4%	-$26.6K	0.21%	129
2025 Q2	$4.91M	Sell	94,400 -3,600	-4%	-$205K	0.18%	171
2025 Q1	$6.25M	Sell	98,000 -8,200	-8%	-$476K	0.32%	48
2024 Q4	$5.08M	Buy	106,200 +100	+0.1%	+$5.13K	0.26%	77
2024 Q3	$6.07M	Sell	106,100 -2,300	-2%	-$132K	0.47%	47
2024 Q2	$5.68M	Sell	108,400 -4,500	-4%	-$197K	0.45%	50
2024 Q1	$4.59M	Buy	+112,900	New	+$4.23M	0.36%	89
2021 Q2	–	Sell	-77,800	Closed	-$3.24M	–	605
2021 Q1	$3.24M	Buy	77,800 +800	+1%	+$36.5K	0.27%	131
2020 Q4	$3.29M	Buy	+77,000	New	+$2.77M	0.31%	114
2020 Q1	–	Sell	-43,300	Closed	-$768K	–	627
2019 Q4	$768K	Sell	43,300 -6,000	-12%	-$104K	0.07%	278
2019 Q3	$765K	Buy	+49,300	New	+$812K	0.07%	265